- Companies
- NB Aurora
NB Aurora Valuation Multiples
NB Aurora is valued at $386M, a 4.8x revenue multiple. In the last fiscal year, NB Aurora revenue was $43M and NB Aurora EBITDA was $10M.
NB Aurora Overview
About NB Aurora
NB Aurora is a Luxembourg-based private equity vehicle promoted by Neuberger Berman that invests in Italian small and medium-sized companies. Its Class A shares were listed on the professional segment of the MIV market of Borsa Italiana, and by mid-2021 it had directly invested more than EUR 268 million in eight Italian companies. It takes majority and active minority stakes with tickets of EUR 20 million to EUR 60 million in growth and expansion capital. At the end of 2024 its net asset value exceeded EUR 339 million and it held twelve portfolio companies, including Farmo, Club del Sole, Dierre Group, Exacer, PromoPharma and Ca' Zampa. In 2025 it was converted into the semi-liquid evergreen fund Aurora Growth Capital, with annual redemption rights, and its delisting from Borsa Italiana followed from the new structure.
Founded
2017
HQ
Employees
N/A
Website
Sectors
Financials (Last FY)
EV
$205M
Valuation Multiples
Start free trialNB Aurora Financials
NB Aurora reported last fiscal year revenue of $43M and EBITDA of $10M.
In the same fiscal year, NB Aurora generated $39M in gross profit, $10M in EBITDA, and $15M in net income.
NB Aurora P&L
In the most recent fiscal year, NB Aurora reported revenue of $43M and EBITDA of $10M.
NB Aurora is profitable as of last fiscal year, with gross margin of 90%, EBITDA margin of 22%, and net margin of 36%.
Financial data powered by Morningstar, Inc.
NB Aurora Stock Performance
NB Aurora has current market cap of $386M, and enterprise value of $205M.
NB Aurora's stock price is $15.74.
NB Aurora has an EPS (earnings per share) of $0.62.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $205M | $386M | 0.0% | - | - | - | $0.62 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNB Aurora Valuation Multiples
NB Aurora trades at 4.8x EV/Revenue multiple, and 21.2x EV/EBITDA.
NB Aurora Financial Valuation Multiples
As of October 20, 2026, NB Aurora has market cap of $386M and EV of $205M.
NB Aurora has a P/E ratio of 25.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NB Aurora Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


NB Aurora Margins & Growth Rates
In the most recent fiscal year, NB Aurora reported gross margin of 90%, EBITDA margin of 22%, and net margin of 36%.
NB Aurora Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
NB Aurora Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
NB Aurora Competitors
NB Aurora competitors include Republic Digital Acq, MCI Capital, Qalaa Holdings, Acacia Research, Kinea Securities FII, Pembroke VCT, Deutsche Beteiligungs, Chrysalis Investments, International Biotechnology Trust and Auroora Group.
Most NB Aurora public comparables operate across PE & VC.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | - | - | |||
| $28M | $22M | 16.1x | - | 20.8x | - | |||
| $2.5B | $427M | 1.2x | - | 6.9x | - | |||
| $285M | $72M | 0.7x | 0.8x | 2.9x | 6.3x | |||
| $55M | $45M | 6.2x | - | 7.5x | - | |||
| $16M | - | 21.2x | - | - | - | |||
| $135M | $45M | 4.3x | 10.9x | 13.0x | 99.6x | |||
| $167M | - | 2.4x | 44.7x | - | - | |||
This data is available for Pro users. Sign up to see all NB Aurora competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by NB Aurora
NB Aurora has acquired 1 company to date.
Last acquisition by NB Aurora was on October 13th 2025. NB Aurora acquired Genetic for undisclosed valuation.
Latest Acquisitions by NB Aurora
| Description | Genetic is an Italian pharmaceutical company operating globally, serving major international pharmaceutical groups and reaching nearly five million patients a year. It exports more than 40 percent of its production to over 40 countries. Its subsidiary Genetic Pharma sells pharmaceuticals directly to pharmacies and wholesalers, and its subsidiary Genelife makes food supplements and medical devices. CVC Capital Partners Strategic Opportunities II and the Pavese family were its shareholders before the 2025 sale. The Pavese family reinvested alongside the new owners in a 50-50 partnership. Aurora Growth Capital, the renamed NB Aurora, acquired the company jointly with Renaissance Partners. |
| HQ Country | |
| HQ City | - |
| Deal Date | 13 Oct 2025 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all NB Aurora acquisitions and their M&A valuation multiples. Start Free Trial | |
Investments by NB Aurora
NB Aurora has invested in 2 companies to date.
Latest investment by NB Aurora was on September 28th 2021. NB Aurora invested in Farmo in their Strategic investment round.
Latest Investments by NB Aurora
| Description | Farmo is a family-owned Italian company that makes gluten-free, high-protein and keto-friendly 'better for you' foods. It produces entirely in Italy at a 20,000 square metre site in Casorezzo, in the province of Milan, covering research and development, production and distribution. The company turned to the gluten-free sector in 2000 under Remo Giai and became the main Italian exporter of such products to the United States and Canada. Private-label products dominate its business, with over 65 percent of sales in the USA and Canada and about 30 percent in Europe. It employs 80 people and generated revenue of about EUR 20 million in 2020, around 35 percent more than in 2019. | Club del Sole is an Italian operator of camping villages headquartered in Forli. Giancarlo Giondi founded the group in 1974, and the Giondi family, including Riccardo and Massimo Giondi, controlled it at the time of the 2015 investment. The group runs holiday villages with bungalows, mobile homes and tent-style housing along the Adriatic Riviera of Emilia-Romagna, on the Blue Flag beaches of Roseto degli Abruzzi, on the Argentario coast in Tuscany and on Lake Garda. In 2015 its camping-village activities were contributed to a new company, Club del Sole srl, in which Emisys took a minority stake through a capital increase. The group aimed to enter the management of new sites already identified. In 2018 the press described it as the sector leader in Italy. |
| HQ Country | ||
| HQ City | Casorezzo | Forli |
| Deal Date | 28 Sep 2021 | 27 Dec 2018 |
| Round | Strategic investment | Secondary |
| Raised | undisclosed | undisclosed |
| Investors | NB Aurora | NB Aurora |
| Valuation | $36M | $143M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all NB Aurora investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NB Aurora
| When was NB Aurora founded? | NB Aurora was founded in 2017. |
| Where is NB Aurora headquartered? | NB Aurora is headquartered in Italy. |
| Is NB Aurora publicly listed? | Yes, NB Aurora is a public company listed on Borsa Italiana. |
| What is the stock symbol of NB Aurora? | NB Aurora trades under AUR ticker. |
| When did NB Aurora go public? | NB Aurora went public in 2018. |
| Who are competitors of NB Aurora? | NB Aurora main competitors include Republic Digital Acq, MCI Capital, Qalaa Holdings, Acacia Research, Kinea Securities FII, Pembroke VCT, Deutsche Beteiligungs, Chrysalis Investments, International Biotechnology Trust, Auroora Group. |
| What is the current market cap of NB Aurora? | NB Aurora's current market cap is $386M. |
| What is the current revenue of NB Aurora? | NB Aurora's last fiscal year revenue is $43M. |
| What is the current EV/Revenue multiple of NB Aurora? | Current revenue multiple of NB Aurora is 4.8x. |
| Is NB Aurora profitable? | No, NB Aurora is not profitable. |
| How many companies NB Aurora has acquired to date? | As of October 2026, NB Aurora has acquired 1 company. |
| What was the largest acquisition by NB Aurora? | None of the M&A deals NB Aurora has completed have disclosed valuations. |
| What companies NB Aurora acquired? | NB Aurora acquired Genetic. |
| In how many companies NB Aurora has invested to date? | As of October 2026, NB Aurora has invested in 2 companies. |
| What was the last NB Aurora investment? | On 28th September 2021 NB Aurora invested in Farmo, participating in a Strategic investment round at $36M valuation. |
| In what companies NB Aurora invested in? | NB Aurora invested in Club del Sole and Farmo. |
See public comps similar to NB Aurora
Lists including NB Aurora
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




